New target for central nervous system drug development
Tuesday, January 19, 2010 - 18:28
in Biology & Nature
Scientists have discovered that the small molecule withaferin-A simultaneously targets two intermediate filaments, GFAP and vimentin, which are implicated in reactive gliosis, a damaging biological process common to a variety of diseases of the central nervous system and eye.